FDA Inspection
Shanghai Hengrui Pharmaceutical Co., Ltd.Shanghai Hengrui Pharmaceutical Co., Ltd. – FDA Inspection, Oct 25, 2024
Record Details
This FDA Inspection record concerns Shanghai Hengrui Pharmaceutical Co., Ltd., with an inspection on October 25, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- October 25, 2024
- Product Type
- Human Drugs
View Company Profile
ID · 71e9f880-30b1-40c7-9e66-32ce9105e679
Inspection Facts
- Inspection number
- 1252840
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shanghai Hengrui Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shanghai Hengrui Pharmaceutical Co., Ltd.
- FDA Inspection 1063523 - 2018-07-20
- FDA Inspection 921475 - 2015-03-27
- FDA Inspection 850208 - 2013-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.